scispace - formally typeset
L

Lee J. Martin

Researcher at Johns Hopkins University School of Medicine

Publications -  254
Citations -  26446

Lee J. Martin is an academic researcher from Johns Hopkins University School of Medicine. The author has contributed to research in topics: Neurodegeneration & Glutamate receptor. The author has an hindex of 80, co-authored 252 publications receiving 25183 citations. Previous affiliations of Lee J. Martin include University of Mainz & University of California, San Francisco.

Papers
More filters
Journal ArticleDOI

Localization of neuronal and glial glutamate transporters

TL;DR: The cellular and subcellular distributions of the glutamate transporter subtypes EAAC1, GLT-1, and GLAST in the rat CNS were demonstrated using anti-peptide antibodies that recognize the C-terminal domains of each transporter.
Journal ArticleDOI

Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis.

TL;DR: Developing C‐terminal, antioligopeptide antibodies that were specific for each glutamate transporter subtype found that GLT‐1 immunoreactive protein was severely decreased in ALS, both in motor cortex (71% decrease compared with control) and in spinal cord.
Journal ArticleDOI

Decreased Glutamate Transport by the Brain and Spinal Cord in Amyotrophic Lateral Sclerosis

TL;DR: ALS is associated with a defect in high-affinity glutamate transport that has disease, region, and chemical specificity and could lead to neurotoxic levels of extracellular glutamate and thus be pathogenic in ALS.
Journal ArticleDOI

Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death.

TL;DR: Cdk5(-/-) mice exhibit unique lesions in the central nervous system associated with perinatal mortality and also suggest that Cdk5 may play critical roles in neuronal cytoskeleton structure and organization.
Journal ArticleDOI

Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport.

TL;DR: It is suggested that APP is synthesized in neurons and delivered to dystrophic nerve endings, where subsequent alterations of local processing of APP result in deposits of brain amyloid.